NMSCX
Price
$24.55
Change
-$0.02 (-0.08%)
Updated
Jul 31 closing price
Net Assets
2.66B
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

NMSCX vs VSCIX

NMSCX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
NMSCX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NMSCX is a Hold and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. NMSCX (2.66B). VSCIX pays higher dividends than NMSCX: VSCIX (1.23) vs NMSCX (1.08). NMSCX was incepted earlier than VSCIX: NMSCX (30 years) vs VSCIX (29 years). NMSCX (0.20) is less costly to investors than VSCIX (0.03). NMSCX is a more actively managed with annual turnover of: 22.00 vs. VSCIX (17.00). NMSCX has a lower initial minimum investment than VSCIX: NMSCX (2000) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 22.58 vs. NMSCX (17.18). VSCIX return over 5 years is better than : 35.13 vs. NMSCX (-12.16).
NMSCXVSCIXNMSCX / VSCIX
Total Expense Ratio0.200.03667%
Annual Report Gross Expense Ratio0.200.03667%
Fund Existence30 years29 years-
Gain YTD13.64414.59194%
Front LoadN/AN/A-
Min. Initial Investment200050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.66B189B1%
Annual Yield % from dividends1.081.2388%
Returns for 1 year17.1822.5876%
Returns for 3 years5.0943.4412%
Returns for 5 years-12.1635.13-35%
Returns for 10 years23.55156.0715%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C